NDC 17856-1126-01 - MAX Tussin Cough and Chest Congestion DM Sugar Free
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1126
- Requested NDC
- 17856-1126-01
- Package NDCs from labels
- 17856-1126-3, 17856-1126-1, 17856-1126-4, 17856-1126-2, 17856-1126-5, 17856-1126-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2026-10-23 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1126-1 | MAX Tussin Cough and Chest Congestion DM Sugar Free | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 2 | |
| 17856-1126-2 | MAX Tussin Cough and Chest Congestion DM Sugar Free | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 2 | |
| 17856-1126-3 | MAX Tussin Cough and Chest Congestion DM Sugar Free | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 2 | |
| 17856-1126-4 | MAX Tussin Cough and Chest Congestion DM Sugar Free | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1126 | MAX TUSSIN COUGH AND CHEST CONGESTION DM SUGAR FREE (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, 4 package rows | 20250514_8f496c61-41a6-41ba-80f5-7a5309c4d18b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1126-1 | ML - Milliliter | 17856-1126 | 4715352a-68a3-45d7-874f-0e1c3c00f84a | 1 | 2025-05-14 |
| 17856-1126-2 | ML - Milliliter | 17856-1126 | 4da2e351-fcfd-4e8d-ad82-fa96e3ed240d | 1 | 2025-03-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OneSsip Diphenhydramine HCl 12.5 mg/ 5 mL Oral Solution | DIPHENHYDRAMINE HCL | MEDWISE LIFESCIENCES INC. | 407b7cbb-7ebd-7b7e-e063-6394a90af501 | 2025-10-06 | Warnings | M012 |
| Quality Choice Medicated Chest Rub | CAMPHOR, MENTHOL, EUCALYPTUS OIL | Quality Choice (CHAIN DRUG MARKETING ASSOCIATION) | d0cce0a0-a6bc-4c45-b9c6-08865b61c1dc | 2025-10-06 | Warnings | M012 L7T10EIP3A |
| Halls Sugar Free Honey Lemon | MENTHOL | Mondelez Global LLC | 2b19fdd2-8088-47f2-be20-f220a6b825fc | 2025-10-06 | Warnings | M012 L7T10EIP3A |
| Giltuss Childrens Cough and Chest Congestion | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Dextrum Laboratories, Inc | 40802fb6-c1ec-d7b0-e063-6394a90ab423 | 2025-10-06 | Warnings | M012 996520 9D2RTI9KYH 495W7451VQ |
| Giltuss Diabetic | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Dextrum Laboratories, Inc | 3f64c81a-bbfc-4575-e063-6294a90a6ed7 | 2025-10-06 | Warnings | M012 996520 495W7451VQ |
| TexaClear Severe Cough, Cold and Flu | CHOLINE SALICYLATE, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | GM Pharmaceuticals, INC | cb99e5b3-1908-43c9-b31f-d35e7ce58b44 | 2025-10-06 | Warnings | M012 9D2RTI9KYH 495W7451VQ |
| SinuLief | LORATADINE | RoseWell Pharmaceuticals LLC | 32619143-a782-3497-e063-6394a90aaaec | 2025-10-06 | Warnings | M012 |
| Kidnex IV | GINKGO BILOBA, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALICUM ACIDUM, PYRUVIC ACID, SUCCINICUM ACIDUM, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, GERMANIUM SESQUIOXIDE, MERCURIUS VIVUS, NUX VOMICA, KIDNEY (SUIS), LYMPH NODE (SUIS), NAPHTHOCHINONUM, NATRUM OXALACETICUM, PHOSPHORUS, URINARY BLADDER (SUIS), ACONITICUM ACIDUM, CIS- | Energique, Inc. | 121eb51a-befe-47ea-85c6-d77e8c7e5864 | 2025-10-06 | Warnings | XF417D3PSL |
| STAHIST AD | CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | Magna Pharmaceuticals, Inc. | ccedbc38-2479-4c35-9f86-a9f29bcfab3f | 2025-10-03 | Warnings | M012 |
| Childrens PediaClear 8 | PYRILAMINE MALEATE | GM Pharmaceuticals, INC | 8e524967-d01c-4c93-9198-c42f15fe3fe0 | 2025-10-03 | Warnings | M012 |
| Childrens PediaClear PD | TRIPROLIDINE HYDROCHLORIDE | GM Pharmaceuticals, INC | f3ede5b7-1b0f-493a-b647-4459affc7e54 | 2025-10-03 | Warnings | M012 |
| Mucus D | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | L. Perrigo Company | 86993cd9-5d55-4a70-8a33-701d91482292 | 2025-10-03 | Warnings | 495W7451VQ |
| mucus D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | L. Perrigo Company | db6ada8a-1799-4d35-8bda-4a322fbd7a06 | 2025-10-03 | Warnings | 495W7451VQ |
| Guaifenesin and Dextromethorphan Hydrobromide | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | InvaTech Pharma Solutions LLC | 40288ecf-043d-eb9e-e063-6394a90ac0a7 | 2025-10-02 | Warnings | M012 9D2RTI9KYH 495W7451VQ |
| Guaifenesin 400 | GUAIFENESIN TABLETS 400 | InvaTech Pharma Solutions LLC | 40291505-55ca-0759-e063-6394a90acee1 | 2025-10-02 | M012 495W7451VQ | |
| HealthWise Pain Relief | MENTHOL | Veridian Healthcare | 06be5331-7a1e-4ab3-9f17-2d350bd4b890 | 2025-10-02 | Warnings | L7T10EIP3A |
| AsperFlex HOT | CAMPHOR, MENTHOL, METHYL SALICYLATE | Akron Pharma Inc. | a6cb0656-8866-44ff-b40c-73655ff68721 | 2025-10-02 | Warnings | L7T10EIP3A |
| AsperFlex Original Maximum Strength | MENTHOL | Akron Pharma Inc. | d766c61e-c48b-4aff-97b0-678159479e03 | 2025-10-02 | Warnings | L7T10EIP3A |
| CVS Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | CVS Pharmacy | 3dd5b783-5b64-24b5-e063-6394a90ab4ee | 2025-10-02 | Warnings | M012 |
| Acetaminophen and Diphenhydramine citrate | ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE | InvaTech Pharma Solutions LLC | 403a88fa-e06b-9b6e-e063-6394a90a97b8 | 2025-10-02 | Warnings | M012 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.